Oncology Research and Treatment
Journal Abbreviation: Oncol Res Treat
ISSN: 2296-5270
eISSN: 2296-5262
Publisher: Karger Publishers
Publications (241)
Improved Pseudomonas exotoxin and Mertansine-based Duotoxins for the treatment of hematologic malignancies (2021)
Ammon AM, George R, Mellenthin L, Mackensen A, Mueller F
Conference contribution
Disease concepts of oncological patients in cultural comparison (2021)
Morawa E, Erim Y
Conference contribution
A Taxonomy for Psycho-Oncological Intervention Techniques in an Acute Care Hospital in Germany (2021)
Madl M, Lieb M, Schieber K, Hepp T, Erim Y
Journal article
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study (2021)
Eichler M, Andreou D, Golcher H, Hentschel L, Richter S, Hohenberger P, Kasper B, et al.
Journal article
Onkologie und Ökonomie-wie frei sind wir wirklich in der Behandlung von Patient∗innen? (2021)
Wormann B, Hecken J, Steutel H, Tamm I, Ullmann A, Kappert-Gonther K, Einsele H, et al.
Journal article
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper (2020)
Woermann B, Bokemeyer C, Burmeister T, Koehne CH, Schwab M, Arnold D, Blohmer JU, et al.
Journal article, Review article
Evaluation of pregnancies after allogeneic stem cell transplantation during the last 15years in Germany (2020)
Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, et al.
Conference contribution
Palliative knowledge and self-efficacy expectation of residents before and after palliative care unit rotation - A national study project (2020)
Roehrig T, Oechsle K, Schuler U, Rosenbruch J, Neukirchen M, Hense J, Weber M, et al.
Conference contribution
Influence of CDK4/6 inhibitors on the peripheral immune response in hormone receptor-positive breast cancer (2020)
Peuker CA, Yaghobramzi S, Grunert C, Keilholz L, Hennig S, Schaper S, Brucker S, et al.
Conference contribution
Allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia with ASXL1-, RUNX1- and TP53 mutations (2020)
Egger-Heidrich K, Middeke JM, Schaefer-Eckart K, Kaufmann M, Einsele H, Mueller-Tidow C, Rösler W, et al.
Conference contribution